{
    "code": 0,
    "data": [
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting-Financial Results",
            "news_body": "Outcome of Board Meeting- Financial Results",
            "news_id": "527d0005-6d32-4a0c-b70b-27df5acf4601",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=915aa19c-1c8c-47f8-8297-e7b7b8c8984f.pdf",
            "news_date": "2026-02-12 19:11:40",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "bbc3fcc7-e29d-45d3-8cb0-0424bfa2aa80",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ff782cb-ade9-4f58-910a-f6fcdc89cc55.pdf",
            "news_date": "2025-12-09 20:04:13",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "49247d72-e9df-48fd-8e68-15f2d99f0616",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c6f003d-2a2f-4c28-89fa-fe83b1e31f46.pdf",
            "news_date": "2025-12-06 10:44:17",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": " Audio and Video Recording of Q2 FY26 Earnings Call",
            "news_id": "ae447570-d6f6-4156-9acb-4366b94ee72a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efa611b7-1ebd-4f22-ad38-405b2a9a10f4.pdf",
            "news_date": "2025-11-12 15:17:18",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "6774e4e8-3cfc-4413-9450-0b65d0af92b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2a272c9-3495-4e33-81c5-a3d9ec77cfc2.pdf",
            "news_date": "2025-11-12 08:36:44",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Half Year Ended 30 September 2025",
            "news_body": "Financial results for Quarter and Half year ended 30 September 2025",
            "news_id": "95876985-cbf5-4a84-a26c-b790d1b0829b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec5d9533-ca7c-4d8b-ba32-3c7c3d36a849.pdf",
            "news_date": "2025-11-11 20:29:35",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio and Video Recording of Q1 FY26 Earnings Call",
            "news_id": "a75911a6-6dfd-4653-97c5-e96dd30962e6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15c7c3c0-2053-4747-8e2d-1c15adba4a81.pdf",
            "news_date": "2025-08-08 17:36:38",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "a2c362f9-185c-4026-a6f7-827cbbe1c179",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d463313-de41-416f-8dc6-428934f9a499.pdf",
            "news_date": "2025-08-08 08:22:37",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Financial Results for the Quarter ended June 30 2025",
            "news_id": "b7c56395-a7cb-4050-842f-beedab13ce46",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7be3f098-c01e-461e-af89-23b9691f2341.pdf",
            "news_date": "2025-08-07 20:14:55",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio and Video Recording of Q4 & Full Year FY 25 Earnings Call",
            "news_id": "811c6a33-0332-46e1-9ad9-dcdf96518130",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a04bde7-07d7-412f-b5c5-59e6dc3b76a5.pdf",
            "news_date": "2025-05-09 17:27:47",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "37303ffc-87b6-4a03-abbd-45b317907972",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78061e46-3096-49e0-b74a-a7e87bf557ca.pdf",
            "news_date": "2025-05-09 08:16:07",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Financial Results for the Quarter and Year ended March 31 2025",
            "news_id": "bd8007e7-45b8-49c3-b700-d1ea9fdedf4b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fc373b3-cc1d-4c2f-baed-556215772138.pdf",
            "news_date": "2025-05-08 19:37:04",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q3 FY 25 Earnings Call",
            "news_id": "d8a0bc5a-c54e-4a85-a3a8-ec6119c2c99a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a32fe18-28dc-4621-b7fc-eaf6ce4bf14c.pdf",
            "news_date": "2025-02-07 15:53:07",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Recording Of Q3 FY 25 Earnings Call",
            "news_body": "Audio and Video recordings of Q3 FY 25 Earnings Call is available on the website of the Company",
            "news_id": "ac9a0824-b472-4137-8dc7-80687b652a40",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4ded3d8-7513-4186-ba3e-72d7489859fa.pdf",
            "news_date": "2025-01-31 15:47:49",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Unaudited financial results for the quarter and nine months ended December 31 2024",
            "news_id": "b8dfe0be-0698-4f0f-8a2a-f172370daf18",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d37849de-08db-48eb-9097-71fb601eadea.pdf",
            "news_date": "2025-01-30 20:38:02",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call Q2 FY 25",
            "news_id": "c8ec5d81-1bd1-47f6-9d6d-bb8c2e0dc982",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=baf1eafd-7d2f-4259-8adc-30d9296f9ca2.pdf",
            "news_date": "2024-11-07 21:33:24",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Half-Year Ended September 30, 2024",
            "news_body": "Unaudited Standalone and Consolidated Financial Results for quarter and half-year ended September 30, 2024",
            "news_id": "3999b13a-cbd1-4b83-9382-7a26c458f62f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24b0f96c-aa30-4fb3-bbca-7ffca25131b0.pdf",
            "news_date": "2024-10-30 17:40:29",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript",
            "news_id": "0c2feed3-ff0f-44e4-89d4-55ac5e249dcf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b334f45-b247-4601-abaa-5c8af7cf8678.pdf",
            "news_date": "2024-08-19 17:27:28",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "c311c502-2b5e-42d5-9494-3fd0c85309eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50b54493-f87d-4b55-a1dd-8a3d9d7c6cf7.pdf",
            "news_date": "2024-06-27 18:35:39",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call Q4 FY24.",
            "news_id": "21cb1650-4c24-4690-94d9-56764a4e9af0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f159a165-0f85-42be-abe3-2a6d924f316b.pdf",
            "news_date": "2024-05-23 15:12:07",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting And Audited Financial Results For The Financial Year Ended 31.03.2024",
            "news_body": "Outcome of Board meeting and Audited Financials Results for the financial year ended 31.03.2024",
            "news_id": "87ed2b4a-bd63-41dc-a97c-20a87c5b6c52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=310a17b3-aea7-4e54-b8a3-e210a8a7b386.pdf",
            "news_date": "2024-05-16 17:16:08",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call Q3 FY24",
            "news_id": "25c1201b-db8b-4d8d-bcc8-4dc2464a7cdb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9eca3da3-52bc-4667-9964-0b117be02a9a.pdf",
            "news_date": "2024-02-16 22:15:52",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation- Q3 FY24",
            "news_id": "1ca48fbd-37b6-437c-8f9a-a3f72ea47cce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1faf964-b133-4f61-83ea-87e7d3140f64.pdf",
            "news_date": "2024-02-09 14:32:10",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting And Results For The Quarter Ended 31.12.2023",
            "news_body": "Outcome of Board meeting",
            "news_id": "eca4a0e9-82fb-4b6a-89e1-4040eeeee1b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15e78e40-91a3-40f9-8ca3-1b477eb2c1a0.pdf",
            "news_date": "2024-02-08 19:08:49",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "7281f23c-e9a4-40e2-b493-ffe506ab3150",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=554a9e88-c630-4823-b56f-6e17a39cfebe.pdf",
            "news_date": "2024-02-08 19:05:20",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached transcript of earnings call held on 10.11.2023",
            "news_id": "92cf5b1b-2717-49f4-93c2-69c5495cf00d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1f49757-0537-431b-bb00-5c5cafaf9a69.pdf",
            "news_date": "2023-11-20 21:42:20",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pls find enclosed Investor Presentation - Q2 FY24.",
            "news_id": "c4ec2f44-42c4-488d-b698-0a3c58a8d12a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60ea6ae1-9441-438b-b6ec-dc44ff35cdd0.pdf",
            "news_date": "2023-11-17 18:27:00",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half-Year Ended September 30, 2023",
            "news_body": "Outcome of Board Meeting and Financial Results for the quarter and half-year ended September 30, 2023",
            "news_id": "dd39b321-886a-4628-a305-40b261076c56",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=566be9b6-34a9-4d02-bb54-15c3ba9c1eff.pdf",
            "news_date": "2023-11-10 16:24:09",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call Q1 FY24",
            "news_id": "ff24d844-c899-48d3-8e16-907497e17626",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c7f0468-f809-4870-9d82-b89e47cd86b9.pdf",
            "news_date": "2023-08-21 13:44:19",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation-Q1 FY24",
            "news_id": "b9252292-7d98-485c-b82f-97dcef2a66cb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33930727-cf2d-4487-9459-b296e13d8e59.pdf",
            "news_date": "2023-08-11 14:59:16",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For Quarter Ended 30.06.23",
            "news_body": "Results",
            "news_id": "d47fe630-2d50-4509-b660-91647892de3d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dca8cc28-0757-4e42-b710-509689e8a4cc.pdf",
            "news_date": "2023-08-10 19:54:21",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is further to our earlier letter dated May 24, 2023 regarding presentation and video recording of Q4 and full year FY23 Earnings Call held on May 24, 2023, please find enclosed herewith the transcript of the Earnings Call. The same is also available on the website of the Company at https://www.biocon.com/investor-relations/financial-information/earning-call-transcripts/",
            "news_id": "4b6cd7e3-2275-47d4-afde-81a915fb9989",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=848b6f1c-184a-435d-8a9c-4c2cd5bc8fb2.pdf",
            "news_date": "2023-05-31 17:07:36",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed the Investor Presentation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations').",
            "news_id": "5e92e2ea-748e-4f77-be1a-536764b1f0a2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f80b745-f4a0-4a34-85bc-9e7e50c9e35e.pdf",
            "news_date": "2023-05-24 16:03:30",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Year Ended March 31, 2023.",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, ('SEBI Listing Regulations') we wish to inform you that the Board of Directors at its meeting held today, i.e. on Tuesday, May 23, 2023, inter alia, has considered the financial results for the financial year ended March 31, 2023.",
            "news_id": "54d1898b-ad77-403b-9e27-70f24a31a2b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6985d846-002f-490d-bdf0-7d180065b5b9.pdf",
            "news_date": "2023-05-23 20:05:50",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call Q3 FY23",
            "news_id": "96bb4eac-cb23-4962-b3cc-2c4d61c351e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88958a58-cd38-4752-999c-4c7518b6158f.pdf",
            "news_date": "2023-02-22 10:15:38",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "With reference to the captioned subject, please find enclosed the Investor Presentation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations').The above information will also be available on the website of the Company at https://www.biocon.com.",
            "news_id": "40502d3a-8502-4d0d-a42f-1864a95df710",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebae8459-65bd-4ef6-954a-df439305d01c.pdf",
            "news_date": "2023-02-17 18:54:38",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On February 14, 2023",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations<BR> 2015 ('SEBI Listing Regulations'), we wish to inform you that the Board of Directors at its meeting held<BR> today, i.e. on Tuesday, February 14, 2023 has approved the un-audited financial results (standalone and<BR> consolidated) of the Company prepared as per Indian Accounting Standard (Ind-AS) along with Limited<BR> Review Report thereon for the quarter and nine-months ended December 31, 2022. A copy of the unaudited<BR> financial results along with the Limited Review Report and is enclosed herewith.<BR> The above information will also be available on the website of the Company at www.biocon.com.<BR> Further, the Board Meeting commenced at 3:30 p.m. and concluded at 6:50 p.m.<BR> Kindly take the above information on record and acknowledge.",
            "news_id": "a5609d9d-91a8-4089-9570-b4008288efad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a059703-4026-4628-9764-568bebcefad8.pdf",
            "news_date": "2023-02-14 19:18:39",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is further to our earlier letter dated November 15, 2022 regarding presentation and video recording of Q2 FY23 Earnings Call held on November 15, 2022, please find enclosed herewith the transcript of the Earnings Call. The same is also available on the website of the Company at https://www.biocon.com/investor-relations/financial-information/earning-call-transcripts/.Kindly take the above said information on record.",
            "news_id": "54a0dbf2-7faa-4b38-9c63-d58b1f20c97a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7ad2652-2dcf-4e00-ba4b-ef4b208fa7a7.pdf",
            "news_date": "2022-11-22 17:20:20",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "With reference to the captioned subject, please find enclosed the Investor Presentation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations').The above information will also be available on the website of the Company at www.biocon.com.",
            "news_id": "4ab6096c-be11-4e9b-a64c-38290f2aa5ca",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9ffd54e-81f7-45b7-8f41-602f42d4eabf.pdf",
            "news_date": "2022-11-15 11:31:40",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On November 14, 2022",
            "news_body": "Dear Sir/Madam,Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, ('SEBI Listing Regulations') we wish to inform you that the Board of Directors at its meeting held today, i.e. on Monday, November 14, 2022, inter alia, has Approved the un-audited financial results (standalone and consolidated) of the Company prepared as per Indian Accounting Standard (Ind-AS) along with Limited Review Report thereon for the quarter and half-year ended September 30, 2022 along with few other matters.",
            "news_id": "47eeeecf-3e86-4f1c-a513-9ad21e57d604",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b22ce8d-b34e-432e-9d85-512e1c8e7e5e.pdf",
            "news_date": "2022-11-14 20:21:36",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14, 2022",
            "news_body": "Dear Sir/Madam,<BR> Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, ('SEBI Listing Regulations') we wish to inform you that the Board of Directors at its meeting held today, i.e. on Monday, November 14, 2022, inter alia, has Approved the un-audited financial results (standalone and consolidated) of the Company prepared as per Indian Accounting Standard (Ind-AS) along with Limited Review Report thereon for the quarter and half-year ended September 30, 2022 along with few other matters.",
            "news_id": "b9d323f4-ab4e-4a69-9b1e-0a06cd6ff5a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f02c2c4f-4ac1-49e4-ae68-71735b497e64.pdf",
            "news_date": "2022-11-14 20:18:35",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is further to our earlier letter dated July 28, 2022 regarding presentation and video recordingof Q1 FY23 Earnings Call held on July 28, 2022, please find enclosed herewith the transcript ofthe Earnings Call. The same is also available on the website of the Company athttps://www.biocon.com/investor-relations/financial-information/earning-calltranscripts/#1599024728333-3499b540-46d3.",
            "news_id": "c654bcf6-0a05-4e30-b8e7-739407d182fc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d35e599d-92a2-407f-bc5d-2a85763377ae.pdf",
            "news_date": "2022-08-03 19:29:23",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is further to our earlier letter dated April 29, 2022 regarding presentation and video recording of Q4 and full year FY22 Earnings Call held on April 29, 2022, please find enclosed herewith the transcript of the Earnings Call. The same is also available on the website of the Company at https://www.biocon.com/investor-relations/financial-information/earning-call-transcripts/.",
            "news_id": "0116159b-0013-4eb2-9a86-4386f76cb7c7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ccb42ced-c193-4745-ade0-eb0336e4a529.pdf",
            "news_date": "2022-05-06 17:47:43",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Updated Q4 and full year FY22 Investor Presentation",
            "news_id": "380a0c3b-6d6a-498d-8991-9d1db133dcf6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6aa3153-3b05-4f16-bf57-97674bce448b.pdf",
            "news_date": "2022-04-29 15:24:07",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "55844787-0dbd-4ef0-8be0-9e7fab04c8af",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=564f702d-a867-4b3b-8937-0e05036d301c.pdf",
            "news_date": "2022-04-28 21:39:10",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results For The Quarter And Year Ended March 31, 2022",
            "news_body": "Financial Results for the quarter and year ended March 31, 2022",
            "news_id": "5ef25e3f-ae3f-4f12-9983-69c82ac582ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3a55049-a08c-4e71-99a3-b6c1e3bfce8f.pdf",
            "news_date": "2022-04-28 20:51:29",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Year Ended March 31, 2022.",
            "news_body": "Financial Results for the quarter and year ended March 31, 2022.",
            "news_id": "1fb64744-4472-486b-9174-740e9641d515",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=168edb5a-c74d-4aea-ba00-d146b2348d76.pdf",
            "news_date": "2022-04-28 20:46:02",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Biocon Biologics to acquire Viatris' Biosimilars Business.",
            "news_id": "3a5399f9-c20e-4aea-a4bf-b36fe1cec69b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=829d014f-21f4-4bf1-951e-70ed70505582.pdf",
            "news_date": "2022-02-28 13:38:24",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "e0e8a3a6-a1b3-4468-91c3-2de50aedf24d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4200892-c60a-41e5-8cf1-2a3004214547.pdf",
            "news_date": "2022-01-20 22:35:06",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended December 31, 2021",
            "news_body": "Financial Results for the quarter ended December 31, 2021",
            "news_id": "a169398e-ae7a-432f-838c-3707ab484982",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24e4379f-f179-4123-93e2-e64ab2e4d9cc.pdf",
            "news_date": "2022-01-20 22:01:42",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q2 FY-22.",
            "news_id": "6770f29d-6e4f-4937-9215-829bc62e91be",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b7f2ad1-e471-41c9-a9e5-a985bd14d56a.pdf",
            "news_date": "2021-11-02 11:00:18",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30, 2021.",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (Listing Obligation and Disclosure Requirements) 2015, we wish to inform you that the Board of Directors at its meeting held today, has considered and approved the un-audited financial results (standalone and consolidated) as per Indian Accounting Standard (Ind-AS) along with Limited Review Report for the quarter and half year ended September 30, 2021. A copy of the un-audited financial results along with the Limited Review Report is enclosed herewith.",
            "news_id": "677aa0cd-9d76-44eb-a4fb-3db3878ec550",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=178bdfc6-a488-4eac-8407-bcf1bc7c75c2.pdf",
            "news_date": "2021-10-21 23:18:08",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation-Q1 FY22",
            "news_id": "447ebd7d-b199-492d-9165-a3670df3226d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24e21a3f-f263-47b3-b032-718bd51f4fec.pdf",
            "news_date": "2021-09-21 16:19:58",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2021.",
            "news_body": "Financial Results for the quarter ended June 30, 2021.",
            "news_id": "90d083b1-edfe-408a-bde4-144e58b99ac2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=255f48f8-457d-4d49-afdd-8f4e76e3d62c.pdf",
            "news_date": "2021-07-22 23:35:48",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2021",
            "news_body": "Financial Results for the quarter ended June 30, 2021",
            "news_id": "0b0fc274-e89f-4a63-a959-f159df6b3fb3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34737ce2-9e1e-4e47-a048-131dddb242d1.pdf",
            "news_date": "2021-07-22 23:33:47",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q4 FY-21.",
            "news_id": "54180873-5c28-48e5-a66e-8cf1fafcd816",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d4680c1-23ba-4c91-86a2-cf6b3c338a9c.pdf",
            "news_date": "2021-05-19 11:35:44",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Financial Results",
            "news_body": "Financial results for the quarter and year ended March 31, 2021.",
            "news_id": "350d75b3-accc-4203-a95e-e0596c7e1791",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf3f1232-1ce2-4fd7-9f86-80608dfd639d.pdf",
            "news_date": "2021-04-28 23:53:46",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2021.",
            "news_body": "Approved audited financial results (consolidated and standalone) as per Indian Accounting Standard (Ind-AS) along with Auditors' Report for the quarter and year ended March 31, 2021. A copy of the audited financial results along with the Auditors' Report and a declaration under Regulation 33(3)(d) of SEBI Listing Regulations are enclosed herewith.",
            "news_id": "048b9fd2-e280-42a3-8f1b-6533ffc8344c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=743bee6f-29ec-4a0d-be6d-6332d0a9962a.pdf",
            "news_date": "2021-04-28 23:49:05",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOCON",
            "disp": "Biocon",
            "bse_code": 532523,
            "isin": "INE376G01013",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "27ada172-9af2-42a8-bfdb-74f792fdc5a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ac36f40-d22e-43ba-bc6b-3fe384d8e85f.pdf",
            "news_date": "2021-04-01 16:15:48",
            "seo": "biocon-ltd",
            "ltp": 375.2,
            "ch": 4.149999999999977,
            "pch": 1.1184476485648773,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11373,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}